{"id":3482,"date":"2017-02-22T11:00:00","date_gmt":"2017-02-22T11:00:00","guid":{"rendered":"https:\/\/chromogenics.dev.phosdev.se\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/"},"modified":"2021-12-09T14:36:20","modified_gmt":"2021-12-09T14:36:20","slug":"chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north","status":"publish","type":"post","link":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/","title":{"rendered":"ChromoGenics offentligg\u00f6r till\u00e4ggsprospekt i samband med notering p\u00e5 Nasdaq First North"},"content":{"rendered":"<p><em>EJ F\u00d6R PUBLICERING, DISTRIBUTION ELLER OFFENTLIGG\u00d6RANDE, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, KANADA, JAPAN ELLER N\u00c5GON ANNAN JURISDIKTION D\u00c4R DISTRIBUTION ELLER OFFENTLIGG\u00d6RANDE SKULLE VARA OTILL\u00c5TEN ENLIGT TILL\u00c4MPLIG LAG. SE \u00c4VEN AVSNITTET VIKTIG INFORMATION NEDAN.<\/em><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>ChromoGenics AB (publ) har uppr\u00e4ttat ett till\u00e4ggsprospekt till det prospekt avseende inbjudan till teckning av Units i ChromoGenics inf\u00f6r listning p\u00e5 Nasdaq First North som godk\u00e4ndes och registrerades av Finansinspektionen den 8 februari 2017. Till\u00e4ggsprospektet \u00e4r en del av och ska l\u00e4sas tillsammans med Prospektet.<\/strong><\/p>\n<p>Till\u00e4ggsprospektet har uppr\u00e4ttats med anledning av att ChromoGenics styrelse kan komma att reglera garantiers\u00e4ttningen till garanterna genom riktad emission om h\u00f6gst 500\u00a0000 aktier samt, i likhet med Erbjudandet, genom tilldelning av en teckningsoption per aktie vederlagsfritt (tillsammans en \u201d<strong>Unit<\/strong>\u201d). Totalt kan h\u00f6gst 500 000 Units tilldelas garanterna som garantiers\u00e4ttning. Till\u00e4ggsprospektet har idag godk\u00e4nts av Finansinspektionen och finns tillg\u00e4ngligt p\u00e5 <a href=\"https:\/\/chromogenics.com\/\">ChromoGenics<\/a>.<\/p>\n<p>Investerare som f\u00f6re offentligg\u00f6randet av Till\u00e4ggsprospektet har gjort en anm\u00e4lan eller p\u00e5 annat s\u00e4tt samtyckt till f\u00f6rv\u00e4rv av Units i Erbjudandet har enligt 2 kap. 34 \u00a7 lagen (1991:980) om handel med finansiella instrument r\u00e4tt att \u00e5terkalla sin anm\u00e4lan eller sitt samtycke inom tv\u00e5 arbetsdagar fr\u00e5n offentligg\u00f6randet av Till\u00e4ggsprospektet, det vill s\u00e4ga senast den 24 februari 2017. \u00c5terkallelse ska ske skriftligen till Aktieinvest FK AB, Emittentservice, 113 89 Stockholm. Investerare som har tecknat genom f\u00f6rvaltare ska kontakta sin f\u00f6rvaltare g\u00e4llande \u00e5terkallelse. Teckning som ej \u00e5terkallas kommer f\u00f6rbli bindande. Om tecknare \u00f6nskar kvarst\u00e5 som tecknare av aktier beh\u00f6vde denne ej vidta n\u00e5gra \u00e5tg\u00e4rder.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong>R\u00c5DGIVARE<\/strong><\/h2>\n<p>G&amp;W Fondkommission \u00e4r finansiell r\u00e5dgivare i samband med erbjudandet och kommer att vara bolagets Certified Adviser p\u00e5 First North. Hannes Snellman Advokatbyr\u00e5 AB \u00e4r legal r\u00e5dgivare avseende svensk r\u00e4tt till ChromoGenics i samband med erbjudandet.<\/p>\n<p>Denna information \u00e4r s\u00e5dan information som ChromoGenics AB (publ) \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning och lagen om v\u00e4rdepappersmarknaden. Informationen l\u00e4mnades, genom nedanst\u00e5ende kontaktpersoners f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 22 februari 2017 kl 12.00\u00a0CET.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong>KONTAKT:<\/strong><\/h2>\n<p>Thomas Almesj\u00f6, VD<br \/>\nSusanne Andersson, CFO &amp; Kommunikationschef<br \/>\nTel: +46 (0)18\u00a0430 0430<br \/>\nE-mail: <a href=\"mailto:info@chromogenics.com\" target=\"_blank\" rel=\"noopener\">info@chromogenics.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<h3><strong>VIKTIG INFORMATION<\/strong><\/h3>\n<p>Detta dokument har inte blivit godk\u00e4nt av n\u00e5gon regulatorisk myndighet. Dokumentet \u00e4r ett pressmeddelande och inte ett prospekt och investerare ska inte teckna eller k\u00f6pa v\u00e4rdepapper som avses i detta dokument f\u00f6rutom p\u00e5 grundval av den information som finns i det prospekt som har godk\u00e4nts av Finansinspektionen och kommer h\u00e5llas tillg\u00e4ngligt p\u00e5 bolagets hemsida. Distributionen av detta pressmeddelande kan i vissa jurisdiktioner vara f\u00f6rem\u00e5l f\u00f6r restriktioner enligt lag och personer som f\u00e5r tillg\u00e5ng till detta, eller del av detta, b\u00f6r informera sig om och f\u00f6lja s\u00e5dana legala restriktioner. Informationen i detta pressmeddelande ska inte utg\u00f6ra ett erbjudande om att s\u00e4lja aktier eller en uppmaning om att k\u00f6pa aktier, inte heller ska det ske n\u00e5gon f\u00f6rs\u00e4ljning av de v\u00e4rdepapper vilka refereras till h\u00e4ri, i n\u00e5gon jurisdiktion d\u00e4r ett s\u00e5dant erbjudande, uppmaning om att k\u00f6pa eller f\u00f6rs\u00e4ljning skulle kr\u00e4va framtagande av ytterligare prospekt eller annan erbjudandehandling, eller inte skulle vara lagenlig utan registrering eller till\u00e4mpligt undantag fr\u00e5n registrering enligt v\u00e4rdepapperslagarna i s\u00e5dan jurisdiktion.<\/p>\n<p>Detta pressmeddelande varken utg\u00f6r, eller utg\u00f6r en del av, ett erbjudande eller en uppmaning om ett erbjudande att k\u00f6pa eller teckna v\u00e4rdepapper i USA. V\u00e4rdepapperna omn\u00e4mnda h\u00e4ri har inte och kommer inte registreras i enlighet med den amerikanska Securities Act fr\u00e5n 1933 (\u201dSecurities Act\u201d), och f\u00e5r inte erbjudas eller s\u00e4ljas i USA utan registrering i enlighet med Securities Act eller ett d\u00e4rtill relaterat undantag. V\u00e4rdepapper omn\u00e4mnda h\u00e4ri erbjuds inte till allm\u00e4nheten i USA. Kopior av detta pressmeddelande g\u00f6rs inte och f\u00e5r inte distribueras eller skickas, i sin helhet eller delvis, direkt eller indirekt, till Australien, Hong Kong, Japan, Kanada, Nya Zeeland, Schweiz, Singapore, Sydafrika eller USA eller till n\u00e5gon annan jurisdiktion d\u00e4r distributionen respektive utskicket av detta pressmeddelande skulle vara olagligt.<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>Om ChromoGenics<\/strong><\/h3>\n<p>ChromoGenics \u00e4r ledande inom dynamiska glas med kontrollerbart v\u00e4rme- och ljusinsl\u00e4pp. Bolagets unika elektrokroma teknologi, ConverLight\u2122, ger ett h\u00e5llbart solskydd med \u00f6kad inomhuskomfort och energieffektivitet. Under 2016 p\u00e5b\u00f6rjades f\u00f6rs\u00e4ljning och leveranser till fastighetsprojekt i Skandinavien.<\/p>\n<p>ChromoGenics \u00e4r baserat i Uppsala och h\u00e4rstammar fr\u00e5n v\u00e4rldsledande forskning p\u00e5 \u00c5ngstr\u00f6mlaboratoriet vid Uppsala universitet. Bolaget har cirka 20 anst\u00e4llda och de huvudsakliga \u00e4garna \u00e4r K-Svets Venture AB och New Energy Solutions II K\/S. Bolagets produktionsanl\u00e4ggning har delvis finansierats med ett villkorsl\u00e5n fr\u00e5n Energimyndigheten.<\/p>\n<p><a href=\"https:\/\/chromogenics.com\/\">ChromoGenics<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p class=\"\"><a title=\"Till\u00e4gg till Prospekt daterat 8 feb 2017\" href=\"https:\/\/mb.cision.com\/Main\/15418\/2195763\/633071.pdf\" target=\"_blank\" rel=\"noopener nofollow\">Till\u00e4gg till Prospekt daterat 8 feb 2017<\/a><\/p>\n<p class=\"\"><a title=\"\" href=\"https:\/\/mb.cision.com\/Public\/15418\/2195763\/af94c370cf6b9185.pdf\" target=\"_blank\" rel=\"noopener nofollow\">Pressmeddelande (PDF)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>EJ F\u00d6R PUBLICERING, DISTRIBUTION ELLER OFFENTLIGG\u00d6RANDE, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, KANADA, JAPAN ELLER N\u00c5GON ANNAN JURISDIKTION D\u00c4R DISTRIBUTION ELLER OFFENTLIGG\u00d6RANDE SKULLE VARA OTILL\u00c5TEN ENLIGT TILL\u00c4MPLIG LAG. SE \u00c4VEN AVSNITTET VIKTIG INFORMATION NEDAN.<\/p>\n","protected":false},"author":1,"featured_media":3225,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[],"class_list":["post-3482","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pressmeddelanden","category-37","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Till\u00e4ggsprospekt i offentligg\u00f6rande - ChromoGenics AB<\/title>\n<meta name=\"description\" content=\"ChromoGenics har uppr\u00e4ttat till\u00e4ggsprospekt till det prospekt avseende inbjudan till teckning av units inf\u00f6r listning p\u00e5 Nasdaq First North.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Till\u00e4ggsprospekt i offentligg\u00f6rande - ChromoGenics AB\" \/>\n<meta property=\"og:description\" content=\"ChromoGenics har uppr\u00e4ttat till\u00e4ggsprospekt till det prospekt avseende inbjudan till teckning av units inf\u00f6r listning p\u00e5 Nasdaq First North.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/\" \/>\n<meta property=\"og:site_name\" content=\"ChromoGenics AB\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/chromogenics\" \/>\n<meta property=\"article:published_time\" content=\"2017-02-22T11:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-09T14:36:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"388\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ChromogenicsAB\" \/>\n<meta name=\"twitter:site\" content=\"@ChromogenicsAB\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#\\\/schema\\\/person\\\/7c92fbbac1b88b2f60e31659cd8fdc82\"},\"headline\":\"ChromoGenics offentligg\u00f6r till\u00e4ggsprospekt i samband med notering p\u00e5 Nasdaq First North\",\"datePublished\":\"2017-02-22T11:00:00+00:00\",\"dateModified\":\"2021-12-09T14:36:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/\"},\"wordCount\":830,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/news-chromogenics-2.jpg\",\"articleSection\":[\"Pressmeddelanden\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/\",\"url\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/\",\"name\":\"Till\u00e4ggsprospekt i offentligg\u00f6rande - ChromoGenics AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/news-chromogenics-2.jpg\",\"datePublished\":\"2017-02-22T11:00:00+00:00\",\"dateModified\":\"2021-12-09T14:36:20+00:00\",\"description\":\"ChromoGenics har uppr\u00e4ttat till\u00e4ggsprospekt till det prospekt avseende inbjudan till teckning av units inf\u00f6r listning p\u00e5 Nasdaq First North.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/#primaryimage\",\"url\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/news-chromogenics-2.jpg\",\"contentUrl\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/news-chromogenics-2.jpg\",\"width\":500,\"height\":388,\"caption\":\"ChromoGenics logo over faded white background\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ChromoGenics offentligg\u00f6r till\u00e4ggsprospekt i samband med notering p\u00e5 Nasdaq First North\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#website\",\"url\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/\",\"name\":\"ChromoGenics AB\",\"description\":\"The performance glass pioneers\",\"publisher\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#organization\",\"name\":\"ChromoGenics AB\",\"url\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/ChromoGenics-AB-logo-black.jpeg\",\"contentUrl\":\"https:\\\/\\\/chromogenics.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/ChromoGenics-AB-logo-black.jpeg\",\"width\":1920,\"height\":1080,\"caption\":\"ChromoGenics AB\"},\"image\":{\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/chromogenics\",\"https:\\\/\\\/x.com\\\/ChromogenicsAB\",\"https:\\\/\\\/www.instagram.com\\\/chromogenicsab\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/chromogenics-ab\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCkeqSnhvjErkRgFJo9eBx9Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/chromogenics.com\\\/sv\\\/#\\\/schema\\\/person\\\/7c92fbbac1b88b2f60e31659cd8fdc82\",\"name\":\"admin\",\"sameAs\":[\"https:\\\/\\\/chromogenics.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Till\u00e4ggsprospekt i offentligg\u00f6rande - ChromoGenics AB","description":"ChromoGenics har uppr\u00e4ttat till\u00e4ggsprospekt till det prospekt avseende inbjudan till teckning av units inf\u00f6r listning p\u00e5 Nasdaq First North.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/","og_locale":"sv_SE","og_type":"article","og_title":"Till\u00e4ggsprospekt i offentligg\u00f6rande - ChromoGenics AB","og_description":"ChromoGenics har uppr\u00e4ttat till\u00e4ggsprospekt till det prospekt avseende inbjudan till teckning av units inf\u00f6r listning p\u00e5 Nasdaq First North.","og_url":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/","og_site_name":"ChromoGenics AB","article_publisher":"https:\/\/www.facebook.com\/chromogenics","article_published_time":"2017-02-22T11:00:00+00:00","article_modified_time":"2021-12-09T14:36:20+00:00","og_image":[{"width":500,"height":388,"url":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@ChromogenicsAB","twitter_site":"@ChromogenicsAB","twitter_misc":{"Skriven av":"admin","Ber\u00e4knad l\u00e4stid":"4 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/#article","isPartOf":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/"},"author":{"name":"admin","@id":"https:\/\/chromogenics.com\/sv\/#\/schema\/person\/7c92fbbac1b88b2f60e31659cd8fdc82"},"headline":"ChromoGenics offentligg\u00f6r till\u00e4ggsprospekt i samband med notering p\u00e5 Nasdaq First North","datePublished":"2017-02-22T11:00:00+00:00","dateModified":"2021-12-09T14:36:20+00:00","mainEntityOfPage":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/"},"wordCount":830,"commentCount":0,"publisher":{"@id":"https:\/\/chromogenics.com\/sv\/#organization"},"image":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/#primaryimage"},"thumbnailUrl":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg","articleSection":["Pressmeddelanden"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/","url":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/","name":"Till\u00e4ggsprospekt i offentligg\u00f6rande - ChromoGenics AB","isPartOf":{"@id":"https:\/\/chromogenics.com\/sv\/#website"},"primaryImageOfPage":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/#primaryimage"},"image":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/#primaryimage"},"thumbnailUrl":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg","datePublished":"2017-02-22T11:00:00+00:00","dateModified":"2021-12-09T14:36:20+00:00","description":"ChromoGenics har uppr\u00e4ttat till\u00e4ggsprospekt till det prospekt avseende inbjudan till teckning av units inf\u00f6r listning p\u00e5 Nasdaq First North.","breadcrumb":{"@id":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/#primaryimage","url":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg","contentUrl":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/03\/news-chromogenics-2.jpg","width":500,"height":388,"caption":"ChromoGenics logo over faded white background"},{"@type":"BreadcrumbList","@id":"https:\/\/chromogenics.com\/sv\/chromogenics-offentliggor-tillaggsprospekt-i-samband-med-notering-pa-nasdaq-first-north\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/chromogenics.com\/sv\/"},{"@type":"ListItem","position":2,"name":"ChromoGenics offentligg\u00f6r till\u00e4ggsprospekt i samband med notering p\u00e5 Nasdaq First North"}]},{"@type":"WebSite","@id":"https:\/\/chromogenics.com\/sv\/#website","url":"https:\/\/chromogenics.com\/sv\/","name":"ChromoGenics AB","description":"The performance glass pioneers","publisher":{"@id":"https:\/\/chromogenics.com\/sv\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chromogenics.com\/sv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/chromogenics.com\/sv\/#organization","name":"ChromoGenics AB","url":"https:\/\/chromogenics.com\/sv\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/chromogenics.com\/sv\/#\/schema\/logo\/image\/","url":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/09\/ChromoGenics-AB-logo-black.jpeg","contentUrl":"https:\/\/chromogenics.com\/wp-content\/uploads\/2021\/09\/ChromoGenics-AB-logo-black.jpeg","width":1920,"height":1080,"caption":"ChromoGenics AB"},"image":{"@id":"https:\/\/chromogenics.com\/sv\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/chromogenics","https:\/\/x.com\/ChromogenicsAB","https:\/\/www.instagram.com\/chromogenicsab\/","https:\/\/www.linkedin.com\/company\/chromogenics-ab\/","https:\/\/www.youtube.com\/channel\/UCkeqSnhvjErkRgFJo9eBx9Q"]},{"@type":"Person","@id":"https:\/\/chromogenics.com\/sv\/#\/schema\/person\/7c92fbbac1b88b2f60e31659cd8fdc82","name":"admin","sameAs":["https:\/\/chromogenics.com"]}]}},"_links":{"self":[{"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/posts\/3482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/comments?post=3482"}],"version-history":[{"count":0,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/posts\/3482\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/media\/3225"}],"wp:attachment":[{"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/media?parent=3482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/categories?post=3482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chromogenics.com\/sv\/wp-json\/wp\/v2\/tags?post=3482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}